Brain Pathology, 2022 · DOI: 10.1111/bpa.13070 · Published: January 1, 2022
This study explores the role of lncRNA MEG3 in acute spinal cord injury (ASCI), focusing on its impact on microglia polarization and neuroinflammation. The research investigates how MEG3 affects the M1 polarization of microglia, which contributes to neuroinflammation in ASCI. The study found that lncRNA MEG3 expression is reduced in ASCI and that overexpressing MEG3 can restrain the M1 polarization of microglia, reducing neuroinflammation. This suggests that MEG3 has a protective role in ASCI by modulating the inflammatory response. Further investigation revealed that lncRNA MEG3 regulates microglia polarization through the HuR/A20/NF-κB axis, promoting motor function recovery and reducing neuroinflammation in mice with SCI. This identifies a specific molecular pathway through which MEG3 exerts its beneficial effects.
LncRNA MEG3 could be a potential therapeutic target for treating ASCI by modulating microglia polarization and reducing neuroinflammation.
The HuR/A20/NF-κB axis is a critical pathway in ASCI, and understanding its regulation by lncRNA MEG3 can lead to new treatment strategies.
LncRNA MEG3 levels in serum might serve as a biomarker for assessing the severity and progression of traumatic brain injury (TBI) and ASCI.